Hydroxyurea

/Tag:Hydroxyurea

Abstract Number: 722

FEVERS AND RIGORS: ADVERSE EFFECTS OF HYDROXYUREA IN THE TREATMENT OF MYELOPROLIFERATIVE DISORDER

Case Presentation: An 84-year-old Caucasian male presented to the emergency department with a chief complaint of fevers, rigors and altered mental status. On physical exam, the patient was a well-nourished, well-developed male with a fever [...]

By | 2019-03-11T14:34:06-04:00 March 11th, 2019|Adult, Clinical Vignettes, Hospital Medicine 2019|Comments Off on FEVERS AND RIGORS: ADVERSE EFFECTS OF HYDROXYUREA IN THE TREATMENT OF MYELOPROLIFERATIVE DISORDER

HM2016 Abstract Number: 339

Preventing Pain Crisis & Hospitalizations: Are Patients with Sickle Cell Anemia Prescribed Hydroxyurea When Appropriate?

Background: Hydroxyurea is an FDA approved medication for use in adults with sickle cell disease. Clinical guidelines, based on high quality evidence, recommend its use in all adults with sickle cell anemia and 3 or [...]

By | 2016-02-01T08:00:34-05:00 February 1st, 2016|Research Abstracts, Transitions of Care|Comments Off on Preventing Pain Crisis & Hospitalizations: Are Patients with Sickle Cell Anemia Prescribed Hydroxyurea When Appropriate?